Latest Updates

Asia Pacific to show fast growth rates in the next five years

Commences third batch of Master of Public Health (MPH)

Forays into the Rs 800-crore nasal inhaler segment

Net sales of the pharmaceuticals business grew by 1.2 per cent during the quarter ended December 31, 2014

Celon will supply the product to Lupin for its commercialisation in the US, Canada, Mexico, and other key markets

EBITDA grew by 95 per cent

Consolidated net profit was at Rs 1,147.60 million

The multiple dosing studies are expected to be completed by Q2 2015

In Q3FY15, the net sales / income from operations was at Rs 4,280 crores

Partnership will help its customers respond to the growing needs of the pharmaceutical industry for safe and cost-effective…